| A review on leukotrienes and their receptors with reference to asthma RK Singh, R Tandon, SG Dastidar, A Ray Journal of Asthma 50 (9), 922-931, 2013 | 146 | 2013 |
| Hemoglobin endocytosis in Leishmania is mediated through a 46-kDa protein located in the flagellar pocket S Sengupta, J Tripathi, R Tandon, M Raje, RP Roy, SK Basu, ... Journal of Biological Chemistry 274 (5), 2758-2765, 1999 | 89 | 1999 |
| Growth factor receptor-binding protein 10 (Grb10) as a partner of phosphatidylinositol 3-kinase in metabolic insulin action Y Deng, S Bhattacharya, OR Swamy, R Tandon, Y Wang, R Janda, ... Journal of Biological Chemistry 278 (41), 39311-39322, 2003 | 85 | 2003 |
| Rab5‐mediated endosome–endosome fusion regulates hemoglobin endocytosis in Leishmania donovani SB Singh, R Tandon, G Krishnamurthy, R Vikram, N Sharma, SK Basu, ... The EMBO journal, 2003 | 70 | 2003 |
| Cinnamic acid, from the bark of Cinnamomum cassia, regulates glucose transport via activation of GLUT4 on L6 myotubes in a phosphatidylinositol 3‐kinase … BS Lakshmi, S Sujatha, S Anand, KN Sangeetha, RB Narayanan, ... Journal of diabetes 1 (2), 99-106, 2009 | 68 | 2009 |
| Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment R Tandon, S Kapoor, S Vali, V Senthil, D Nithya, R Venkataramanan, ... European journal of pharmacology 667 (1-3), 56-65, 2011 | 44 | 2011 |
| Increase in weight induced by muraglitazar, a dual PPARα/γ agonist, in db/db mice: adipogenesis/or oedema? S Mittra, G Sangle, R Tandon, S Sharma, S Roy, V Khanna, A Gupta, ... British journal of pharmacology 150 (4), 480-487, 2007 | 37 | 2007 |
| Enhanced expression of recombinant proteins utilizing a modified baculovirus expression vector P Tiwari, S Saini, S Upmanyu, B Benjamin, R Tandon, KS Saini, S Sahdev Molecular biotechnology 46, 80-89, 2010 | 26 | 2010 |
| Essential role of PSM/SH2‐B variants in insulin receptor catalytic activation and the resulting cellular responses M Zhang, Y Deng, R Tandon, C Bai, H Riedel Journal of cellular biochemistry 103 (1), 162-181, 2008 | 22 | 2008 |
| Immunomodulation by opioid peptidomimetic compound P Narayan, VK Singh, SS Agarwal, R Tandon, W Haq, R Raghubir, ... Neuroimmunomodulation 9 (3), 134-140, 2001 | 22 | 2001 |
| Progress in the development of small molecule inhibitors of insulin-like growth factor-1 receptor kinase PKS Sarma, R Tandon, P Gupta, SG Dastidar, A Ray, B Das, IA Cliffe Expert Opinion on Therapeutic Patents 17 (1), 25-35, 2007 | 13 | 2007 |
| RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy R Tandon, V Senthil, D Nithya, V Pamidiboina, A Kumar, S Malik, T Chaira, ... European journal of pharmacology 711 (1-3), 19-26, 2013 | 10 | 2013 |
| Inhibition of antigen specific lymphocyte proliferation and cytokine stimulation by peptidomimetic opioid compound P Narayan, R Tandon, W Haq, MM Dhar, VK Singh International immunopharmacology 2 (6), 751-757, 2002 | 9 | 2002 |
| Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice R Tandon, A Soni, RK Singh, R Sodhi, MK Seth, S Sinha, S Sahdev, ... European Journal of Pharmacology 886, 173391, 2020 | 6 | 2020 |
| Mechanism of action of Anti-diabetic property of Cinnamic acid, a principal active ingredient from the bark of Cinnamomum cassia R Tandon, A Gupta, A Ray International Journal of Therapeutic Applications 9, 39-45, 2013 | 5 | 2013 |
| Inhibition of anti-CD3 and interleukin-2 stimulated T lymphocyte proliferation by peptidomimetic opioid compound P Narayan, R Pandey, VS Yadav, R Tandon, W Haq, MM Dhar, VK Singh Immunopharmacology and immunotoxicology 25 (2), 225-233, 2003 | 3 | 2003 |
| Synthesis of novel tetrapeptides as potential ACE inhibitors R Tandon, MP Singh, W Haq, M Dikshit, GK Patnaik, MM Dhar NISCAIR-CSIR, India, 1997 | 2 | 1997 |
| Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma SA Visaga, H Kalonia, V Verma, S Sinha, SK Singh, S Upadhyay, ... bioRxiv, 2021.09. 16.460577, 2021 | 1 | 2021 |
| Design, synthesis, and SAR of 2-acetamido-3-pyrrolidinepropanamide derivatives as urotensin-II receptor antagonists A Soni, A Agarwal, S Saha, M Das, K Shripati, S Aeron, B Das, I Cliffe, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015 | | 2015 |
| Dual EGFR/IGFR inhibitor: A novel approach to overcome resistance P Gupta, J Dullu, Y Khaimar, P Saha, R Kumar, A Siddiqui, R Tandon, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 245, 2013 | | 2013 |
Vijay K. SinghProfessor, F. Edward Hébert School of Medicine, AFRRI, USUHSVerified email at usuhs.edu
